FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012494940> ?p ?o ?g. }

• W2012494940 endingPage "2516" @default.
• W2012494940 startingPage "2508" @default.
• W2012494940 abstract "Background. Survivors of advanced Hodgkin disease, who were assigned randomly to treatment by mechlorethamine, vincristine, procarbazine, and prednisone (MOPP); doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD); or MOPP alternating with ABVD in a clinical trial of the Cancer and Leukemia Group B (protocol 8251), were compared in terms of their psychosocial adaptation and psychosexual function an average of 2.2 years after completion of treatment (range, 1-5 years). The study was undertaken to determine if there were differences among treatments in these functional areas as a consequence of differential long-term gonadal damage in the three regimens. Methods. Ninety-three disease-free survivors of advanced Hodgkin disease (56 men and 37 women) were studied (a minimum of 1 year after completion of treatment) by an interview conducted over the telephone. Standardized measures were used to assess their psychologic, sexual, family, and vocational functioning, including the following tests: the Psychosocial Adjustment to Illness Scale-Self Report, the Brief Symptom Inventory, the Profile of Mood States, and the Impact of Event Scale. Results. Contrary to expectation, no statistically significant differences in survivors' psychosocial adaptation or psychosexual function were found by treatment arm. Infertility (based on survivors' reports of medical test results and perceptions) and lower income 1 year before the diagnosis of cancer were significant predictors of poorer adjustment. Most survivors reported a range of problems that they attributed to having had cancer: 35%, proven or perceived infertility; 24%, sexual problems; 31%, health and life insurance problems; 26%, a negative socioeconomic effect; and 51%, conditioned nausea, associated with visual or olfactory reminders of chemotherapy. Conclusions. No significant long-term advantage in psychosocial adaptation or psychosexual function was found for survivors of Hodgkin disease treated by the less gonadally toxic ABVD regimen 1 to 5 years after completion of treatment." @default.
• W2012494940 created "2016-06-24" @default.
• W2012494940 creator A5007613973 @default.
• W2012494940 creator A5013145785 @default.
• W2012494940 creator A5027339880 @default.
• W2012494940 creator A5028502712 @default.
• W2012494940 creator A5028949419 @default.
• W2012494940 creator A5032265429 @default.
• W2012494940 creator A5037466690 @default.
• W2012494940 creator A5039180386 @default.
• W2012494940 creator A5048077385 @default.
• W2012494940 creator A5062378578 @default.
• W2012494940 creator A5071600139 @default.
• W2012494940 creator A5088697255 @default.
• W2012494940 creator A5088998288 @default.
• W2012494940 date "1992-11-15" @default.
• W2012494940 modified "2023-10-17" @default.
• W2012494940 title "Comparison of psychosocial adaptation and sexual function of survivors of advanced hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD" @default.
• W2012494940 cites W1749428309 @default.
• W2012494940 cites W1808994586 @default.
• W2012494940 cites W1912948805 @default.
• W2012494940 cites W1967309526 @default.
• W2012494940 cites W1967977907 @default.
• W2012494940 cites W1970081529 @default.
• W2012494940 cites W1971067412 @default.
• W2012494940 cites W1980844800 @default.
• W2012494940 cites W2025405867 @default.
• W2012494940 cites W2035277953 @default.
• W2012494940 cites W2038493041 @default.
• W2012494940 cites W2043309268 @default.
• W2012494940 cites W2047569501 @default.
• W2012494940 cites W2052129237 @default.
• W2012494940 cites W2063357448 @default.
• W2012494940 cites W2066358461 @default.
• W2012494940 cites W2073940260 @default.
• W2012494940 cites W2085424111 @default.
• W2012494940 cites W2085992423 @default.
• W2012494940 cites W2091594296 @default.
• W2012494940 cites W2097445334 @default.
• W2012494940 cites W2098043510 @default.
• W2012494940 cites W2122491991 @default.
• W2012494940 cites W2128328547 @default.
• W2012494940 cites W2161488267 @default.
• W2012494940 cites W2165866682 @default.
• W2012494940 cites W2324824120 @default.
• W2012494940 cites W4205875664 @default.
• W2012494940 cites W4237306883 @default.
• W2012494940 cites W4300666352 @default.
• W2012494940 cites W4317928731 @default.
• W2012494940 doi "https://doi.org/10.1002/1097-0142(19921115)70:10<2508::aid-cncr2820701020>3.0.co;2-v" @default.
• W2012494940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1384949" @default.
• W2012494940 hasPublicationYear "1992" @default.
• W2012494940 type Work @default.
• W2012494940 sameAs 2012494940 @default.
• W2012494940 citedByCount "69" @default.
• W2012494940 countsByYear W20124949402012 @default.
• W2012494940 countsByYear W20124949402013 @default.
• W2012494940 countsByYear W20124949402014 @default.
• W2012494940 countsByYear W20124949402016 @default.
• W2012494940 countsByYear W20124949402018 @default.
• W2012494940 countsByYear W20124949402019 @default.
• W2012494940 countsByYear W20124949402020 @default.
• W2012494940 countsByYear W20124949402021 @default.
• W2012494940 countsByYear W20124949402023 @default.
• W2012494940 crossrefType "journal-article" @default.
• W2012494940 hasAuthorship W2012494940A5007613973 @default.
• W2012494940 hasAuthorship W2012494940A5013145785 @default.
• W2012494940 hasAuthorship W2012494940A5027339880 @default.
• W2012494940 hasAuthorship W2012494940A5028502712 @default.
• W2012494940 hasAuthorship W2012494940A5028949419 @default.
• W2012494940 hasAuthorship W2012494940A5032265429 @default.
• W2012494940 hasAuthorship W2012494940A5037466690 @default.
• W2012494940 hasAuthorship W2012494940A5039180386 @default.
• W2012494940 hasAuthorship W2012494940A5048077385 @default.
• W2012494940 hasAuthorship W2012494940A5062378578 @default.
• W2012494940 hasAuthorship W2012494940A5071600139 @default.
• W2012494940 hasAuthorship W2012494940A5088697255 @default.
• W2012494940 hasAuthorship W2012494940A5088998288 @default.
• W2012494940 hasConcept C118552586 @default.
• W2012494940 hasConcept C126322002 @default.
• W2012494940 hasConcept C150966472 @default.
• W2012494940 hasConcept C1862650 @default.
• W2012494940 hasConcept C187212893 @default.
• W2012494940 hasConcept C2775871022 @default.
• W2012494940 hasConcept C2776305933 @default.
• W2012494940 hasConcept C2776694085 @default.
• W2012494940 hasConcept C2776755627 @default.
• W2012494940 hasConcept C2779112685 @default.
• W2012494940 hasConcept C2779429289 @default.
• W2012494940 hasConcept C2780964509 @default.
• W2012494940 hasConcept C71924100 @default.
• W2012494940 hasConceptScore W2012494940C118552586 @default.
• W2012494940 hasConceptScore W2012494940C126322002 @default.
• W2012494940 hasConceptScore W2012494940C150966472 @default.
• W2012494940 hasConceptScore W2012494940C1862650 @default.
• W2012494940 hasConceptScore W2012494940C187212893 @default.
• W2012494940 hasConceptScore W2012494940C2775871022 @default.
• W2012494940 hasConceptScore W2012494940C2776305933 @default.

• next